日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy

利用CAR-T细胞疗法靶向TROP2,根除EGFR突变型非小细胞肺癌中的耐药性持续细胞

Simon Baldacci ,Elliott J Brea ,Francesco Facchinetti ,Zhaorong Li ,Kenneth Ngo ,Soumya Malhotra ,Matthew A Booker ,Michael Yevgeniy Tolstorukov ,Sachiv Chakravarti ,Conor Hinchey ,Navin R Mahadevan ,Filippo Lococo ,Simona D'Agnelli ,Letizia Gnetti ,Nicoletta Campanini ,Alessandro Leonetti ,William W Feng ,Jeanelle A Tsai ,Antja-Voy Hartley ,Marie-Anaïs Locquet ,Ludovic Fournel ,Marco Alifano ,Audrey Mansuet-Lupo ,Aisha Saldanha ,William Haller ,Lauren M Zasadil ,Magdalena Zielinska ,Karen Bui ,Bishma Tuladhar ,Patrick Hall Lizotte ,Elena V Ivanova ,Lecia V Sequist ,Prafulla C Gokhale ,Cloud P Paweletz ,Eric L Smith ,Pasi A Jänne ,David A Barbie

EMAP-II from macrophage-derived extracellular vesicles drives neutrophil extracellular traps formation via PI3K/AKT/mtROS in lung ischemia/reperfusion injury

巨噬细胞来源的细胞外囊泡产生的 EMAP-II 通过 PI3K/AKT/mtROS 通路驱动肺缺血/再灌注损伤中的中性粒细胞胞外陷阱形成。

Hanhong Zhuang ,Xuemei Song ,Jiemei Li ,Zhao Li ,Siyi Wu ,Peng Wang ,Honglei Shen ,Xiaojing He ,Youyuan Guo ,Zhiping Li ,Fei Lin

Preclinical evaluation of antitumor activity and toxicity of TROP2-specific CAR-T cells for treatment of triple-negative breast cancer

TROP2特异性CAR-T细胞治疗三阴性乳腺癌的抗肿瘤活性和毒性临床前评价

Shiyu Sun # ,Xiaojia Wang # ,Yongchen Chen ,Ziwei Liang ,Zuomin Nian ,Wanni Xu ,Wenzhou Wang ,Li Yan ,Fei Wu ,Huizi Wu ,Yiwei Jia ,Lu Zhang ,Shuqun Zhang ,Yang Xu ,Xingcong Ma

Pretargeted Trop-2 ImmunoPET for Rapid, Selective Detection of Pancreatic Tumors

预靶向Trop-2免疫PET用于快速、选择性检测胰腺肿瘤

Edwin C Pratt ,Komal Mandleywala ,David Bauer ,Alexander Bolaender ,Grace Chao ,Mark A Castanares ,Emily C Collins ,Jason S Lewis

Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors

系统性改造TROP2靶向CAR T细胞疗法可克服实体瘤的耐药通路

Elliott J Brea,Simon Baldacci,Neil Savage,Francesco Facchinetti,Conor Hinchey,Sachiv Chakravarti,Alexis Mottram,Kenneth Ngo,Ha Vo,Brittaney A Leeper,Bishma Tuladhar,Suthakar Ganapathy,Elena V Ivanova,Aisha Saldanha,Marie-Anais Locquet,Abdulmajeed Salamah,Malcolm Holterhus,Evelyn B Mesler,Martina De Vizio,Carla Stornante,Marco Campisi,Navin R Mahadevan,Tran C Thai,Timothy J Haggerty,Zehua Li,Cui Nie,Changjing Deng,Xiaoxiao Wang,Louis L Liu,Thanh U Barbie,Prafulla C Gokhale,Cloud P Paweletz,Anusuya Ramasubramanian,Pasi A Jänne,David A Barbie,Eric L Smith

The Citron homology domain of MAP4Ks improves outcomes of traumatic brain injury

MAP4K 的 Citron 同源结构域可改善创伤性脑损伤的预后

Xiaoling Zhong ,Wenjiao Tai ,Meng-Lu Liu ,Shuaipeng Ma ,Tianjin Shen ,Yuhua Zou ,Chun-Li Zhang

Chromosome-level genome assembly of the obligate cave loach Troglonectes daqikongensis

专性洞穴鳅(Troglonectes daqikongensis)的染色体水平基因组组装

Houhua Bing ,Wenyu Fang ,Jiayang He ,Yongrui Lu ,Zichen Xiong ,Jun Xu ,Guohuan Su

Preclinical Pharmacokinetic, Pharmacodynamic, and Safety Profile of OBI-992: A Novel TROP2-Targeted Antibody-Drug Conjugate

OBI-992 的临床前药代动力学、药效学和安全性概况:一种新型的靶向 TROP2 的抗体-药物偶联物

Chi-Sheng Shia ,Shih-Ni Wen ,Ren-Yu Hsu ,Jyy-Shiuan Tu ,Hui-Wen Chang ,Hao-Cheng Weng ,Jhih-Jie Yang ,Ming-Feng Chiang ,Yu-Hsuan Tsao ,Chi-Huan Lu ,Yu-Hung Chen ,Yi-Chen Wu ,Ya-Chi Chen ,Wan-Fen Li ,Teng-Yi Huang ,Ming-Tain Lai

Novel Amanitin-Based Antibody-Drug Conjugates Targeting TROP2 for the Treatment of Pancreatic Cancer

新型基于鹅膏蕈碱的抗体药物偶联物靶向TROP2治疗胰腺癌

Eleni Papacharisi ,Alexandra C Braun ,Marija Vranic ,Andreas M Pahl ,Torsten Hechler

Oxidized LDL stimulates PKM2-mediated mtROS production and phagocytosis

氧化型低密度脂蛋白刺激PKM2介导的线粒体活性氧(mtROS)生成和吞噬作用

Jue Zhang ,Jackie Chang ,Vaya Chen ,Mirza Ahmar Beg ,Wenxin Huang ,Lance Vick ,Yaxin Wang ,Heng Zhang ,Erin Yttre ,Ankan Gupta ,Mark Castleberry ,Ziyu Zhang ,Wen Dai ,Jieqing Zhu ,Shan Song ,Moua Yang ,Ashley Kaye Brown ,Zhen Xu ,Yan-Qing Ma ,Brian C Smith ,Jacek Zielonka ,James G Traylor Jr ,Cyrine Ben Dhaou ,A Wayne Orr ,Weiguo Cui ,Yiliang Chen